ELV
Elevance Health Inc
Elevance Health Inc historical holders
total: 18
Pzena Investment Management Elevance Health Inc transactions over time
- Total transactions:
- 23
- New positions:
- 2
- Sold out:
- 1
- Added:
- 12
- Reduced:
- 8
- Held since:
- 2021 Q3
- Held for:
- 20 quarters
- Latest activity:
- 2026 Q2
Richard Pzena has been an institutional investor in Elevance Health Inc (ELV) since 2019 Q1. According to 2026 Q2 report, Richard Pzena holds 224,575 shares with a market value of roughly $86.85M representing 0.25% of their equity portfolio. The fund/company first acquired ELV in 2019 Q1, initially purchasing 2,830 shares. Richard Pzena later completely sold out the position and reinvested in ELV again in 2021 Q3. Since the initial investment, Pzena Investment Management has made 22 more transactions in this position.
Does Richard Pzena still hold ELV?
Yes, Richard Pzena continues to hold Elevance Health Inc (ELV). According to their 2026 Q2 report, they maintain a position of 224,575 shares valued at approximately $86.85M, representing 0.25% of their equity portfolio.
When did Richard Pzena first invest in ELV?
Richard Pzena first invested in Elevance Health Inc (ELV) in 2019 Q1 at the reported quarter-end price of $286.93 per share, acquiring 2,830 shares in their initial purchase.
What is Richard Pzena's average cost basis for ELV?
Based on historical transaction data, Richard Pzena's estimated cost basis for Elevance Health Inc (ELV) is approximately $376.40 per share. This represents their average reported price* across all buy transactions.
Has Richard Pzena reinvested in ELV after selling?
Yes, Richard Pzena has shown renewed interest in Elevance Health Inc (ELV). After completely selling their position, they reinitiated an investment in 2021 Q3, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $376.40
- Weighted AVG sell price:
- $459.26
ELV transactions history by Pzena Investment Management
23 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
0.25%
|
224,575
|
$386.73
|
$86,849,890
|
+2.00% (+4,399)
|
+0%
|
|
2026 Q1
|
0.21%
|
220,176
|
$292.75
|
$64,456,524
|
+1.78% (+3,854)
|
+0%
|
|
2025 Q4
|
0.23%
|
216,322
|
$350.55
|
$75,831,677
|
-0.18% (-387)
|
-0%
|
|
2025 Q3
|
0.23%
|
216,709
|
$323.12
|
$70,023,012
|
-0.26% (-567)
|
-0%
|
|
2025 Q2
|
0.27%
|
217,276
|
$388.96
|
$84,511,673
|
+8.11% (+16,296)
|
+0.02%
|
|
2025 Q1
|
0.31%
|
200,980
|
$434.96
|
$87,418,261
|
+3.60% (+6,983)
|
+0.01%
|
|
2024 Q4
|
0.24%
|
193,997
|
$368.90
|
$71,565,493
|
+0.85% (+1,629)
|
+0%
|
|
2024 Q3
|
0.32%
|
192,368
|
$520.00
|
$100,031,360
|
+0.06% (+113)
|
+0%
|
|
2024 Q2
|
0.37%
|
192,255
|
$541.86
|
$104,175,294
|
-0.50% (-964)
|
-0%
|
|
2024 Q1
|
0.34%
|
193,219
|
$518.54
|
$100,191,780
|
-0.17% (-331)
|
-0%
|
|
2023 Q4
|
0.34%
|
$471.56
|
+0.37% (+722)
|
|||
|
2023 Q2
|
0.37%
|
$444.29
|
+0.50% (+965)
|
|||
|
2023 Q1
|
0.38%
|
$459.81
|
+0.09% (+163)
|
|||
|
2022 Q4
|
0.44%
|
$512.97
|
-0.15% (-292)
|
|||
|
2022 Q3
|
0.43%
|
$454.24
|
-0.20% (-380)
|
|||
|
2022 Q2
|
0.42%
|
$482.58
|
+0.85% (+1,626)
|
|||
|
2022 Q1
|
0.35%
|
$491.22
|
+0.14% (+260)
|
|||
|
2021 Q4
|
0.33%
|
$463.54
|
-0.76% (-1,454)
|
|||
|
2021 Q3
|
0.28%
|
$372.80
|
new
|
|||
|
2020 Q1
|
0.00%
|
$301.89
|
-100% (-2,438)
|
|||
|
2019 Q3
|
0.00%
|
$239.95
|
+1.29% (+31)
|
|||
|
2019 Q2
|
0.00%
|
$282.09
|
-14.95% (-423)
|
|||
|
2019 Q1
|
0.00%
|
$286.93
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.